2024 年至 2031 年肩关节置换市场（依手术类型、植入物设计、植入物材料及地区划分）

肩关节置换市场评估，2024 年至 2031 年

个人和政府增加医疗支出使得先进的医疗服务更实惠。扩大保险覆盖范围和报销指南正在增加患者接受肩关节置换手术的机会，有助于推动市场扩张。因此，医疗保健支出的增加正在加速市场规模的成长，到 2024 年市场规模将超过 19.5 亿美元，到 2031 年将达到 33 亿美元的估值。

肥胖、久坐等生活型态因素导致骨关节炎等肩关节疾病的流行。肥胖尤其会对关节造成额外的压力，加速关节退化并增加肩关节置换手术的需要。因此，肥胖和久坐的生活方式将推动市场在 2024 年至 2031 年期间以 7.50% 的复合年增长率成长。

肩关节置换市场定义/概述

肩关节置换术是一种外科手术，其中用人工关节部件（通常称为植入物）替换肩关节中的骨骼。此手术可能是部分的或完全的，取决于肩关节损伤的程度。肩关节置换手术中使用的人工植入物通常由金属和聚乙烯製成。事实证明，肩关节置换手术是一种有效的治疗方法，适用于患有骨关节炎和其他使人衰弱的肩部疾病的患者，尤其是在非手术治疗失败的情况下。

全肩关节置换术是一种成熟的外科手术，旨在恢復关节炎肩部的舒适度和功能。在这次手术中，肩关节的球被一个光滑的金属球取代，该金属球通过一个适合骨头的柄连接到手臂骨（肱骨）。以高密度聚乙烯製成的人工关节重新修復患处的关节窝（关节盂）。在现有的各种外科手术中，肩关节置换手术能最迅速、最全面地改善关节炎肩关节的舒适度和功能。

肩关节置换手术的成功在很大程度上取决于手术的技术准确性以及患者对旨在实现所需运动范围的术后运动计画的坚持。透过遵循结构化的復健计划，患者可以最大限度地享受手术的好处，显着缓解疼痛，并明显改善肩部活动能力。总体而言，肩关节置换手术对于患有严重肩关节问题的人来说是一种非常有效的治疗方法，透过改善关节功能提供新的生活品质。

老年人口的增加和肩关节损伤发生率的提高将如何推动肩关节置换市场的成长？

全球老龄人口的不断增加对肩关节置换市场有利。随着人们寿命的延长，与年龄相关的肩部疾病（如类风湿性关节炎和骨关节炎）变得越来越普遍。易患肩关节退化的长者越来越需要肩关节置换手术来控制疼痛和恢復活动能力。由于创伤、身体活动和工作相关风险以及与年龄相关的状况而导致的肩部损伤发生频率增加促进了市场的成长。这些损伤常常导致慢性疼痛和功能丧失，需要肩关节置换手术来恢復关节功能并缓解不适。例如

美国国家卫生统计中心

在美国，成年人上肢疼痛的盛行率随着年龄的增长而增加，从18-29岁族群的16.2％上升到30-44岁族群的24.1％。45岁至64岁族群的数字达到37.9％，而65岁及以上族群的数字达到42.0％。

植入技术的进步也促进了肩关节置换市场的成长。植入物设计、材料和手术技术的不断创新可改善治疗效果并提高患者满意度。现代植入物具有更高的稳定性、更长的寿命和更大的活动范围，使得肩关节置换术更有效、对患者更具吸引力。此外，患者对肩关节置换手术益处的认知也越来越高。随着人们越来越积极地寻求治疗肩部功能障碍和疼痛，对这些手术的需求也日益增长。越来越多的患者意识到肩关节置换手术可以显着改善活动能力、减轻疼痛并提高整体生活品质。

手术工具和器械的技术进步也促进了肩关节置换市场的成长。机器人辅助手术、导航系统和手术器械的创新正在提高肩关节置换手术的精确度和准确性。这些技术使外科医生能够执行微创手术，从而减少组织损伤并加快恢復时间，从而提高患者对这些手术的接受度和采用率。医疗保健基础设施的扩张，尤其是在新兴国家，进一步推动了市场成长。医疗设施的改善、熟练医务人员数量的增加以及医疗费用的上涨使得人们能够更多地获得先进的医疗治疗，包括肩关节置换手术。

肩关节置换手术的高成本以及感染和血栓的风险如何阻碍肩关节置换市场的成长？

肩关节置换手术是一项昂贵的手术，其费用不仅包括植入物本身。患者面临住院、手术费、康復、止痛药等大量费用，这可能是一个沉重的经济负担，特别是对于那些保险覆盖有限的人来说。例如，在Hyderabad，肩关节置换手术的平均费用一般在 300 万卢比至 80 万卢比之间。费用的差异取决于多种因素，包括手术类型、症状的严重程度、医院设施的品质以及外科医生的熟练程度。儘管有潜在的好处，但任何手术（包括肩关节置换术）的固有风险和併发症可能会让一些患者望而却步。这些风险包括感染、血栓、神经损伤和植入物鬆动，这些风险可能会影响手术的成功并导致进一步的医疗干预。

此外，儘管肩部置换术在许多情况下显示出良好的效果，但关于植入物的耐久性和各种手术技术的有效性的长期数据仍然有限。缺乏全面的长期证据给患者和外科医生带来了不确定性，影响了决策过程。此外，肩关节置换手术并不适合所有人。潜在的市场规模有限，因为年龄、整体健康状况和关节损伤的严重程度等因素在确定手术指征方面起着关键作用。

疼痛管理、物理治疗和非手术治疗（如可的松注射）可以缓解一些肩痛患者疼痛。这些选择可以延迟甚至消除手术介入的需要，进一步影响肩关节置换手术的需求。此外，肩关节置换手术的成功在很大程度上取决于严格的復健计划。手术后，患者必须接受专门的物理治疗以恢復力量、活动能力和活动范围。如此广泛的復健需求可能是一个重大障碍，特别是对于那些难以坚持康復或接受持续物理治疗的患者来说。

目录

第 1 章 简介

• 市场定义
• 市场细分
• 调查方法

第 2 章 执行摘要

• 主要发现
• 市场概况
• 市集亮点

第3章 市场概况

• 市场规模和成长潜力
• 市场趋势
• 市场驱动力
• 市场制约因素
• 市场机会
• 波特五力分析

第4章 肩关节置换术市场（依手术类型划分）

• 全肩关节置换术 (TSA)
• 部分肩关节置换术（半关节置换术）

第5章 肩关节置换市场（依植入物设计）

• 解剖肩关节置换术
• 反肩关节置换术

第6章 肩关节置换市场（依植入材料）

• 金属植入物
• 聚乙烯植入物

第7章 区域分析

• 北美
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 英国
• 德国
• 法国
• 义大利
• 亚太地区
• 中国
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中东/非洲
• 南非
• 沙乌地阿拉伯
• 阿拉伯联合酋长国

第 8 章 市场动态

• 市场驱动力
• 市场制约因素
• 市场机会
• COVID-19 的市场影响

第9章 竞争格局

• 大公司
• 市场占有率分析

第10章 公司简介

• Johnson & Johnson
• Stryker Corporation
• Zimmer Biomet
• Exactech
• Waldemar Link GmbH & Co. KG
• Arthrex, Inc.
• Aesculap AG（subsidiary of B. Braun SE）
• DJO Global, Inc.
• Osteonics Corporation

第11章市场前景与机遇

• 新兴技术
• 未来市场趋势
• 投资机会

第12章 附录

• 缩写表
• 来源和参考文献

Shoulder Replacement Market Valuation - 2024-2031

Rising healthcare spending by both individuals and governments is making sophisticated medical treatments more affordable. Expanded insurance coverage and reimbursement guidelines are increasing patient access to shoulder replacement surgeries, propelling market expansion. Thus, increasing healthcare spending is surging the growth of market size surpassing USD 1.95 Billion in 2024 to reach a valuation of USD 3.3 Billion by 2031.

Lifestyle factors such as obesity and sedentary lifestyles are contributing to the prevalence of shoulder conditions like osteoarthritis. Obesity, in particular, places additional stress on joints, accelerating joint deterioration and the need for shoulder replacement surgery. Thus, obesity and sedentary lifestyles are enabling the growth of market to grow at aCAGR of 7.50% from 2024 to 2031.

Shoulder Replacement Market: Definition/ Overview

Shoulder replacement surgery involves substituting the bones of the shoulder joint with artificial joint components, commonly referred to as implants. This procedure can be performed either partially or completely, depending on the extent of damage to the glenohumeral joint. The prosthetic implants used in shoulder replacement are typically composed of metal and polyethylene. Shoulder joint replacement has proven to be an effective treatment for individuals suffering from osteoarthritis and other debilitating shoulder conditions, especially when nonsurgical treatments have failed to provide relief.

Total shoulder replacement arthroplasty is a well-established surgical procedure aimed at restoring comfort and function to an arthritic shoulder. During this surgery, the arthritic ball of the shoulder joint is replaced with a smooth metal ball that is fixed to the arm bone (humerus) using a stem that fits within the bone. The arthritic socket (glenoid) is resurfaced with a high-density polyethylene prosthesis. Among the various surgical options available, total shoulder replacement offers the most rapid and comprehensive improvement in both comfort and function for shoulders affected by arthritis.

The success of shoulder replacement surgery relies heavily on the technical precision of the procedure and the patient's commitment to a postoperative exercise program designed to achieve the desired range of motion. By following a structured rehabilitation plan, patients can maximize the benefits of the surgery, attaining significant relief from pain and a marked improvement in shoulder mobility. Overall, shoulder replacement surgery stands out as a highly effective intervention for those struggling with severe shoulder joint issues, offering a renewed quality of life through enhanced joint functionality.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

How do the Rising Geriatric Population and Increasing Frequency of Shoulder Injuries Surge the Growth of the Shoulder Replacement Market?

The increasing aging population globally acts as a boon for the shoulder replacement market. As people live longer, age-related shoulder disorders such as rheumatoid arthritis and osteoarthritis become more prevalent. Older adults, who are more susceptible to shoulder joint degeneration, increasingly require shoulder replacement surgeries to manage pain and restore mobility. In addition to age-related conditions, the rising frequency of shoulder injuries due to trauma, sports activities, and work-related risks is contributing to market growth. These injuries often lead to chronic pain and functional impairment, necessitating shoulder replacement surgery to restore joint function and alleviate discomfort. For instance, according to the

National Center for Health Statistics

, in the United States, the prevalence of upper limb pain among adults increases with age, rising from 16.2% in the 18-29 age group to 24.1% among those aged 30-44. This percentage further increases to 37.9% for individuals aged 45-64 and reaches 42.0% for those aged 65 and older.

Advancements in implant technology are also contributing to the growth of the shoulder replacement market. Continuous innovation in implant design, materials, and surgical techniques has led to improved outcomes and higher patient satisfaction. Modern implants offer better stability, longevity, and range of motion, making shoulder replacement surgeries more effective and appealing to patients. Furthermore, there is a growing awareness among patients about the benefits of shoulder replacement surgeries. As people become more proactive in seeking treatment for shoulder dysfunction and pain, the demand for these procedures is increasing. Patients are increasingly aware that shoulder replacement surgeries can significantly improve mobility, reduce pain, and enhance overall quality of life.

Technological advancements in surgical tools and instruments have also contributed to the growth of the shoulder replacement market. Innovations in robotic-assisted surgery, navigation systems, and surgical instruments have enhanced the precision and accuracy of shoulder replacement procedures. These technologies enable surgeons to perform minimally invasive surgeries, which result in less tissue damage and quicker recovery times, thereby increasing patient acceptance and adoption of these procedures. The expansion of healthcare infrastructure, particularly in emerging economies, has further fueled market growth. Improved healthcare facilities, a greater number of skilled medical professionals, and increased healthcare expenditures have enhanced access to advanced medical treatments, including shoulder replacement surgeries.

How the High Cost of Shoulder Replacement Surgery and the Risk of Infection, and Blood Clots is Impeding the Growth of the Shoulder Replacement Market?

Shoulder replacement surgery is an expensive procedure, encompassing costs beyond just the implant itself. Patients face substantial expenses related to hospital stays, surgeon fees, rehabilitation, and pain medication, which can pose a significant financial burden, particularly for those with limited insurance coverage. For instance, in Hyderabad, the average cost of shoulder replacement surgery generally ranges from ₹3 lakhs to ₹8 lakhs. This variation in cost depends on several factors, including the type of procedure, the severity of the condition, the quality of hospital amenities, and the proficiency of the surgeon. Despite the potential benefits, the inherent risks and complications associated with any surgery, including shoulder replacement, can deter some patients. These risks include infection, blood clots, nerve damage, and implant loosening, which can compromise the surgery's success and lead to further medical interventions.

Additionally, while shoulder replacement surgery has demonstrated positive outcomes in many cases, the availability of long-term data on implant durability and the effectiveness of various surgical techniques remains limited. This lack of comprehensive long-term evidence can create uncertainty for both patients and surgeons, influencing the decision-making process. Moreover, shoulder replacement is not suitable for everyone. Factors such as age, overall health, and the severity of joint damage play a critical role in determining candidacy for the procedure, thereby limiting the potential market size.

Non-surgical alternatives, such as pain management, physical therapy, and cortisone injections, offer relief for some patients experiencing shoulder pain. These options can delay or, in some cases, eliminate the need for surgical intervention, further impacting the demand for shoulder replacement surgery. Furthermore, the success of shoulder replacement surgery heavily depends on a rigorous rehabilitation program. Following the procedure, patients must commit to dedicated physical therapy to regain strength, mobility, and range of motion. This requirement for extensive rehabilitation can be a significant hurdle, particularly for those who may struggle with the commitment or face barriers to accessing consistent physical therapy.

Category-Wise Acumens

How the Degenerative Joint Diseases of Shoulder and Advancements in Implants are Surging the Growth of the Anatomic Shoulder Replacement Segment?

Anatomic Shoulder Replacement is showing significant growth in the Shoulder Replacement Market. Arthroplasty has proven to be one of the most reliable treatment options for degenerative joint diseases of the shoulder. Over the past 60 years, there have been significant advancements in implant designs to address initial challenges in arthroplasty, such as restoring function and preventing implant loosening. For instance, according to

the University of North Carolina

report among individuals with osteoarthritis (OA), 43% are aged 65 or older, and 88% are aged 45 or older. The annual incidence of knee OA is highest among those aged 55 to 64. Notably, more than half of individuals with symptomatic knee OA are younger than 65.

Despite the rise of reverse shoulder arthroplasty (RSA) as the most commonly performed type of shoulder replacement in major countries like the United States and the United Kingdom, total anatomical shoulder arthroplasty (TSA) remains a well-established treatment for osteoarthritis in patients with a competent rotator cuff. Patients with osteoarthritis who undergo TSA now expect lasting and significant improvements in pain and function. The demonstrated efficacy of anatomical shoulder arthroplasty suggests that it will gain more attention in the future.

How the Increasing Demand for Surgery's effectiveness Fostering the Growth of the Reverse Shoulder Arthroplasty Segment?

The Reverse Shoulder Arthroplasty (RSA) segment has emerged as the dominant force in the Shoulder Replacement Market. This rise in popularity is attributed to the surgery's effectiveness and its ability to preserve the deltoid muscle, which is crucial for shoulder function. RSA utilizes a specific class of artificial joints designed to restore function to shoulders that have been severely damaged. These prostheses consist of three main components: a stem that is inserted into the humerus bone, a glenoid or socket, and an upper arm component. Unlike anatomic shoulder replacements, where the ball joint is positioned behind the shoulder, RSA places the ball joint above the shoulder. This unique design significantly enhances the stability of the shoulder and provides a wider range of motion for the arm, making it a preferred choice for patients with severe shoulder issues. The ability of RSA to improve functionality and mobility in patients who might otherwise have limited options has solidified its position as a leading treatment in shoulder arthroplasty.

Country/Region-wise Acumens

How the Robust Infrastructure and Sophisticated Surgical Procedures are Surging the Growth of the Shoulder Replacement Market in North America?

The North American region leads the Shoulder Replacement Market and is projected to maintain its dominance throughout the forecast period. This leadership is driven by the presence of major international companies within the medical device industry, positioning the United States and Canada as key hotspots for medical innovation and development. The advanced healthcare systems in these countries further fuel market growth by providing the infrastructure necessary to support sophisticated surgical procedures.

The rising healthcare expenditure in North America. Both the United States and Canada allocate a substantial portion of their GDP to healthcare, facilitating greater investment in advanced medical technologies such as joint replacements. This financial commitment enables the adoption of cutting-edge implants and surgical techniques, enhancing the overall quality and accessibility of shoulder replacement procedures.

Moreover, the emphasis on maintaining active lifestyles across North America, even into older age, has increased the demand for shoulder replacement surgeries. Many individuals prioritize mobility and physical activity, and shoulder replacement surgery allows them to regain function and engage in their desired activities. This focus on active living drives the adoption of surgical interventions to treat debilitating shoulder conditions.

Technological advancements also play a crucial role in the growth of the shoulder replacement market in North America. Continuous innovations in implant design, the development of minimally invasive surgical techniques, and improvements in pain management protocols significantly enhance surgical outcomes and patient recovery. These advancements make shoulder replacement surgery a more attractive and viable option for patients, thereby boosting market growth.

How the Rising Healthcare Expenditures and Increasing Geriatric Population is Escalating the Growth of Shoulder Replacement Market in Asia Pacific?

Asia Pacific is emerging as the fastest-growing region in the Shoulder Replacement Market, fueled by increased healthcare spending and favorable demographic trends. The region's rising healthcare expenditures are translating into significant growth opportunities for both multinational corporations (MNCs) and local medical device players. This trend is supported by an aging population and rising disposable incomes, which have transformed the Asia Pacific into a burgeoning hub for various industries, particularly healthcare.

Moreover, the region's attractiveness is amplified by the growing trend of medical tourism, driven by lower treatment costs compared to Western countries and supportive government regulations that incentivize domestic companies. This environment has enhanced the appeal of Asia Pacific as a lucrative market for shoulder replacement surgeries, particularly in the category of implant types.

The increasing prevalence of chronic diseases and musculoskeletal disorders among the aging population has heightened the demand for advanced orthopedic treatments like shoulder replacements across the Asia Pacific. As healthcare infrastructure continues to develop and regulatory frameworks evolve to support innovation, foreign investments in the region's medical device sector are expected to expand further.

Competitive Landscape

The shoulder replacement market is a dynamic space driven by innovation, value-based care, and strategic partnerships. While major medical device companies hold a dominant position, emerging players with niche solutions and a focus on cost-effectiveness can carve out a space in this competitive landscape.

The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the shoulder replacement market include:

• Johnson & Johnson
• Stryker Corporation
• Zimmer Biomet
• Exactech
• Waldemar Link GmbH & Co. KG
• Arthrex, Inc.
• Aesculap AG (a subsidiary of B. Braun SE)
• DJO Global, Inc.
• Osteonics Corporation
• Shoulder Replacement Market Latest Developments
• In August 2021, Smith Nephew announced the launch of new total ankle and total shoulder replacement technologies as well as showcase its freshly enlarged extremities portfolio during the American Academy of Orthopaedic Surgeons' 2021 Annual Meeting in San Diego.
• In July 2021, Stryker's Tornier shoulder arthroplasty portfolio was announced, together with the Tornier Perform Humeral System.
• In March 2023, Geisinger Health Plan and Medacta Group SA, a Swiss business that specializes in sustainable joint replacement, sports medicine, and spine treatments, announced the first-ever lifetime guarantee for a lumbar spinal fusion procedure.
• In August 2021, The American Academy of Orthopedic Surgeons' 2021 Annual Meeting will be held in San Diego. Smith Nephew will display its newly expanded extremities range, as well as innovative ankle and shoulder replacement technologies.
• In August 2021, Johnson and Johnson revealed the ENHANCE Shoulder System, a fully integrated shoulder arthroplasty system. It enables doctors to simply swap between stemless and stemmed implants during surgical procedures.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Shoulder Replacement Market, By Procedure Type

• Total Shoulder Arthroplasty (TSA)
• Partial Shoulder Arthroplasty (Hemiarthroplasty)

5. Shoulder Replacement Market, By Implant Design

• Anatomic Shoulder Replacement
• Reverse Shoulder Replacement

6. Shoulder Replacement Market, By Implant Material

• Metal Implants
• Polyethylene Implants

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Johnson & Johnson
• Stryker Corporation
• Zimmer Biomet
• Exactech
• Waldemar Link GmbH & Co. KG
• Arthrex, Inc.
• Aesculap AG (subsidiary of B. Braun SE)
• DJO Global, Inc.
• Osteonics Corporation

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References